CNBC May 16, 2023
Ashley Capoot, Annika Kim Constantino

Key Points

– Google Cloud launched two new AI-powered solutions that aim to help biotech and pharmaceutical companies accelerate drug discovery and advance precision medicine.

– The two suites mark Google’s latest advancements in the red-hot AI arms race.

– The solutions also tackle the lengthy and costly process of bringing a new treatment to the U.S. market.

– Big Pharma’s Pfizer and biotech companies Cerevel Therapeutics and Colossal Biosciences are already using the solutions.

Google Cloud on Tuesday launched two new AI-powered tools that aim to help biotech and pharmaceutical companies accelerate drug discovery and advance precision medicine.

One tool, called the Target and Lead Identification Suite, is designed to help companies predict and understand...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Biotechnology, Cloud, Health IT, Pharma, Pharma / Biotech, Precision Medicine, Technology
What Musk is telling Trump on AI regulation is anyone's guess
How AI is Transforming the Acute Patient Journey
Microsoft brings transactional databases to Fabric to boost AI agents
How each generation sees AI: a reflection on adaptation
An AI pressure test

Share This Article